News nuggets you might have missedWhile we are all trying to keep up, sometimes the most important stories that can affect our industry are shoved off to the... Protecting your travel agency in ...
Hosted on MSN1mon
Gyre therapeutics president Ma Songjiang sells $48,029 in stockSAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.1 billion market cap biotech company with a robust current ratio of 3.72, reported selling shares worth $48,029 ...
Hosted on MSN29d
Gyre therapeutics president Ma Songjiang sells $46,360 in stockSAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback